Effects of a Mycelium-derived β-glucan Feed Additive on Nursery Pig Growth Performance, Fecal Dry Matter, and Immune Response

A study was conducted to evaluate the effects of increasing dietary inclusion of a mycelium-derived β-glucan feed additive on growth performance, fecal dry matter, and cytokine responses in nursery pigs. A total of 360 weanling pigs (initial BW = 12.4 ± 0.06 lb) were used in a 45-d study. At weaning, pigs were blocked by three BW categories (light, medium, and heavy) and within BW category pigs were randomly assigned to one of six dietary treatments in a generalized randomized block design. Each treatment consisted of 12 replicate pens with five pigs per pen. The dietary program was typical of commercially formulated diets and consisted of three feeding phases: phase 1 (d 0 to 10), phase 2 (d 10 to 24), and phase 3 (d 24 to 45). The six treatments were: Control (Ctrl): basal diet across all phases; Ctrl + Carbadox: basal diet supplemented with 55 ppm carbadox in all phases; Low β-glucan: basal diet supplemented with β-glucan at 750, 500, and 250 ppm in phases 1, 2, and 3, respectively; Medium-Low β-glucan: basal diet supplemented with β-glucan at 1,000, 750, and 500 ppm in phases 1, 2, and 3, respectively; Medium-High β-glucan: basal diet supplemented with β-glucan at 1,250, 1,000, and 750 ppm in phases 1, 2, and 3, respectively; and High β-glucan: basal diet supplemented with β-glucan at 1,500, 1,250, and 1,000 ppm in phases 1, 2, and 3, respectively. There was no evidence of treatment differences in BW on d 0 and 10; however, by d 24, pigs fed Carbadox had greater BW than Ctrl pigs (P = 0.002), and this response was maintained through d 45, at which time Carbadox-fed pigs had greater BW than Ctrl, Medium-Low, and Medium-High β-glucan pigs (P < 0.05) with the Low and High β-glucan pigs intermediate. From d 0 to 10, ADG, ADFI, and F/G were not affected by treatment. From d 10 to 24, ADG and ADFI were greater in Carbadox-fed pigs compared with Ctrl pigs (P ≤ 0.014), with a tendency for improved F/G (P = 0.078) also observed; however, β-glucan level did not impact performance. From d 24 to 45, ADG and ADFI were improved (P ≤ 0.001) when Carbadox was included in the diet. Although there were no linear or quadratic responses to β-glucan inclusion level, pigs fed the Low and High β-glucan treatments had intermediate ADG and ADFI compared with the Carbadox-fed pigs and the other treatments. Overall (d 0 to 45), Carbadox increased (P ≤ 0.002) ADG, ADFI, and final BW compared with pigs fed the control diet. There were no linear or quadratic growth performance responses to increasing β-glucan in the diet. The Low β-glucan treatment had an intermediate ADG response compared with the Carbadox-fed pigs and the other treatments. For ADFI, all β-glucan treatments were intermediate compared with the Ctrl and Carbadox treatments and for F/G the Low and High β-glucan treatments were intermediate compared with the Carbadox treatment and all other treatments. Treatment affected fecal DM on d 24 and 45 (P < 0.001), with Carbadox-fed pigs having greater fecal DM than the Medium-Low β-glucan pigs on d 24 (P < 0.05) and greater than all other treatments on d 45 (P < 0.05). No linear or quadratic effects of β-glucan inclusion were observed for fecal DM. Carbadox-fed pigs also had lower CRP on d 24 compared with Ctrl and Medium-High β-glucan pigs (P < 0.05) and lower haptoglobin compared with Ctrl and all β-glucan treatments (P < 0.05), although these effects were not maintained on d 45. Treatment affected cytokine responses, including increased GM-CSF (P < 0.05) in pigs fed Medium-High β-glucan compared with Medium-Low and Low β-glucan on d 45. Interferon-γ (IFN-γ) was also affected by treatment on d 45 (P = 0.035), although no mean separation was detected. A linear effect of β-glucan inclusion was observed for IFN-γ (P = 0.019) and a quadratic effect for IL-12 (P = 0.044). No treatment effects were observed for other cytokines. In conclusion, carbadox improved growth performance, fecal DM, and reduced inflammatory markers, whereas mycelium-derived β-glucan supplementation influenced selected immune parameters with the low level of β-glucan resulting in overall ADG and ADFI similar to that of both the control and carbadox treatments in this high-health environment. Additional research in a commercial barn may be warranted, especially with the low β-glucan treatment to determine if the ADG and ADFI benefits can be repeated.

Authors

Institutions

Publication Details

Journal
Kansas Agricultural Experiment Station Research Reports
Published
2026-11-13
DOI
https://doi.org/10.4148/kaesrr.21921
Primary Topic
Animal Nutrition and Physiology
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Effects of a Mycelium-derived β-glucan Feed Additive on Nursery Pig Growth Performance, Fecal Dry Matter, and Immune Response

Joana Magoga, Joel M DeRouchey, Katelyn N. Gaffield, Mike D Tokach et al.
1 links
Kansas Agricultural Experiment Station Research Reports
Animal Nutrition and Physiology
article

Effects of a Mycelium-derived β-glucan Feed Additive on Nursery Pig Growth Performance, Fecal Dry Matter, and Immune Response

Joana Magoga, Joel M DeRouchey, Katelyn N. Gaffield, Mike D Tokach, Robert D Goodband, Jordan T Gebhardt, Jason C Woodworth, Chris Zeager, Peter Karnezos
article en

Abstract

A study was conducted to evaluate the effects of increasing dietary inclusion of a mycelium-derived β-glucan feed additive on growth performance, fecal dry matter, and cytokine responses in nursery pigs. A total of 360 weanling pigs (initial BW = 12.4 ± 0.06 lb) were used in a 45-d study. At weaning, pigs were blocked by three BW categories (light, medium, and heavy) and within BW category pigs were randomly assigned to one of six dietary treatments in a generalized randomized block design. Each treatment consisted of 12 replicate pens with five pigs per pen. The dietary program was typical of commercially formulated diets and consisted of three feeding phases: phase 1 (d 0 to 10), phase 2 (d 10 to 24), and phase 3 (d 24 to 45). The six treatments were: Control (Ctrl): basal diet across all phases; Ctrl + Carbadox: basal diet supplemented with 55 ppm carbadox in all phases; Low β-glucan: basal diet supplemented with β-glucan at 750, 500, and 250 ppm in phases 1, 2, and 3, respectively; Medium-Low β-glucan: basal diet supplemented with β-glucan at 1,000, 750, and 500 ppm in phases 1, 2, and 3, respectively; Medium-High β-glucan: basal diet supplemented with β-glucan at 1,250, 1,000, and 750 ppm in phases 1, 2, and 3, respectively; and High β-glucan: basal diet supplemented with β-glucan at 1,500, 1,250, and 1,000 ppm in phases 1, 2, and 3, respectively. There was no evidence of treatment differences in BW on d 0 and 10; however, by d 24, pigs fed Carbadox had greater BW than Ctrl pigs (P = 0.002), and this response was maintained through d 45, at which time Carbadox-fed pigs had greater BW than Ctrl, Medium-Low, and Medium-High β-glucan pigs (P < 0.05) with the Low and High β-glucan pigs intermediate. From d 0 to 10, ADG, ADFI, and F/G were not affected by treatment. From d 10 to 24, ADG and ADFI were greater in Carbadox-fed pigs compared with Ctrl pigs (P ≤ 0.014), with a tendency for improved F/G (P = 0.078) also observed; however, β-glucan level did not impact performance. From d 24 to 45, ADG and ADFI were improved (P ≤ 0.001) when Carbadox was included in the diet. Although there were no linear or quadratic responses to β-glucan inclusion level, pigs fed the Low and High β-glucan treatments had intermediate ADG and ADFI compared with the Carbadox-fed pigs and the other treatments. Overall (d 0 to 45), Carbadox increased (P ≤ 0.002) ADG, ADFI, and final BW compared with pigs fed the control diet. There were no linear or quadratic growth performance responses to increasing β-glucan in the diet. The Low β-glucan treatment had an intermediate ADG response compared with the Carbadox-fed pigs and the other treatments. For ADFI, all β-glucan treatments were intermediate compared with the Ctrl and Carbadox treatments and for F/G the Low and High β-glucan treatments were intermediate compared with the Carbadox treatment and all other treatments. Treatment affected fecal DM on d 24 and 45 (P < 0.001), with Carbadox-fed pigs having greater fecal DM than the Medium-Low β-glucan pigs on d 24 (P < 0.05) and greater than all other treatments on d 45 (P < 0.05). No linear or quadratic effects of β-glucan inclusion were observed for fecal DM. Carbadox-fed pigs also had lower CRP on d 24 compared with Ctrl and Medium-High β-glucan pigs (P < 0.05) and lower haptoglobin compared with Ctrl and all β-glucan treatments (P < 0.05), although these effects were not maintained on d 45. Treatment affected cytokine responses, including increased GM-CSF (P < 0.05) in pigs fed Medium-High β-glucan compared with Medium-Low and Low β-glucan on d 45. Interferon-γ (IFN-γ) was also affected by treatment on d 45 (P = 0.035), although no mean separation was detected. A linear effect of β-glucan inclusion was observed for IFN-γ (P = 0.019) and a quadratic effect for IL-12 (P = 0.044). No treatment effects were observed for other cytokines. In conclusion, carbadox improved growth performance, fecal DM, and reduced inflammatory markers, whereas mycelium-derived β-glucan supplementation influenced selected immune parameters with the low level of β-glucan resulting in overall ADG and ADFI similar to that of both the control and carbadox treatments in this high-health environment. Additional research in a commercial barn may be warranted, especially with the low β-glucan treatment to determine if the ADG and ADFI benefits can be repeated.

Kansas Agricultural Experiment Station Research ReportsVol. 12(3)
Kansas State University (US)
Zero hunger
Animal Nutrition and Physiology
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon